… Dr Devarajan is a co-inventor on patents submitted for the use of NGAL as a biomarker of
kidney injury, and has licensing agreements with BioPorto, Inc. Dr Ghahramani reported grants …

… proposed definitions for AKI (ie, RIFLE[16] and Acute Kidney Injury Network [AKIN][… AKI will
be operationalized as follows which is anticipated to capture a broad spectrum of kidney injury…

… AKI in a continuum with acute and chronic kidney disease. Biomarkers of kidney injury or stress
are new tools for risk assessment … AKI is not a single disease but rather a loose collection …

… In the future, markers of cellular injury in the kidney will likely define AKI and offer the potential
to diagnose the disorder before functional decline. Until then, the “tried and true” markers …

… the understanding of AKI, and ultimately patient outcomes. … acute kidney injury (AKI) should
include: 1) an assessment of the contributing causes of the kidney injury, 2) an assessment of …

… of AKI, risk assessment for AKI, and prognosis of AKI. … , kidney injury molecule-1, and IL-18
- added to urine microscopic examination is significantly higher over clinical assessment …

… AKI, our ability to assess kidney function is limited and functional impairment poorly correlates
with structural injury to the kidneys. … individuals without kidney injury might fulfill AKI criteria …

… Unfortunately, direct assessment of kidney damage, apart from biopsy, is not possible with
… Certain biomarkers indicate early kidney injury or subclinical acute kidney injury (AKI) as a …

… that sustained kidney injury and … kidney injury and inflammation in patients with AKI, we
measured a panel of noninvasive biomarkers reflecting these processes at 3 time points after AKI …

… kidney injury has replaced acute renal failure to emphasise that a continuum of kidney injury
… Thus, histopathological assessment is used only for rapid post-mortem assessment, which …